Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Lung. 2021 Oct 19;199(6):611–618. doi: 10.1007/s00408-021-00485-z

Table 3:

Comorbidities related to sarcoidosis and its treatment as reported by sarcoidosis patients with lymphoma as compared to those with no lymphoma*

Lymphoma (n=43) No lymphoma (n=86) P value
Cushing’s disease 2(4.7) 3(3.5) 0.747
Diabetes mellitus 5(11.6) 18(21) 0.193
Hypercalcemia 4(9.3) 6(7) 0.641
Obesity 18(42) 30(35) 0.440
Chronic fatigue 18(42) 20(23.3) 0.029
Chronic pain syndrome 16(37.2) 11(12.8) 0.001
Congestive heart failure 4(9.3) 2(2.3) 0.076
Depression 18(42) 19(22.1) 0.019
Fibromyalgia 11(26.2) 8(9.3) 0.012
Hypertension 16(37.2) 16(18.6) 0.021
*

Patients were asked whether they developed any of a list of comorbidities AFTER they were given the diagnosis of sarcoidosis